Bevacizumab and Re-irradiation vs. Bevacizumab alone for Recurrent GBM
Diseases and Conditions Researched
Brain and Nervous System
What is the purpose of this trial?
To establish an improvement in overall survival in recurrent GBM patients receiving bevacizumab and re-irradiation compared with patients receiving bevacizumab alone.
Click here for detailed participation information for this trial.
|Sponsor:||Radiation Therapy Oncology Group|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.